Al-Chalabi, A., van den Berg, L. H., & Veldink, J. (2017). Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nature Reviews Neurology, 13(2), 96–104. https://doi.org/10.1038/nrneurol.2016.182
Andreasson, U., Blennow, K., & Zetterberg, H. (2016). Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 3, 98–102. https://doi.org/10.1016/j.dadm.2016.05.005
Badders, N. M., Korff, A., Miranda, H. C., Vuppala, P. K., Smith, R. B., Winborn, B. J., Quemin, E. R., Sopher, B. L., Dearman, J., Messing, J., Kim, N. C., Moore, J., Freibaum, B. D., Kanagaraj, A. P., Fan, B., Tillman, H., Chen, P.-C., Wang, Y., III, B. B. F., … Taylor, J. P. (2018). Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nature Medicine, 24(4), 427–437. https://doi.org/10.1038/nm.4500
Beitel, L. K., Alvarado, C., Mokhtar, S., Paliouras, M., & Trifiro, M. (2013). Mechanisms Mediating Spinal and Bulbar Muscular Atrophy: Investigations into Polyglutamine-Expanded Androgen Receptor Function and Dysfunction. Frontiers in Neurology, 4. https://doi.org/10.3389/fneur.2013.00053
Belaya, K., Rodríguez Cruz, P. M., Liu, W. W., Maxwell, S., McGowan, S., Farrugia, M. E., Petty, R., Walls, T. J., Sedghi, M., Basiri, K., Yue, W. W., Sarkozy, A., Bertoli, M., Pitt, M., Kennett, R., Schaefer, A., Bushby, K., Parton, M., Lochmüller, H., … Beeson, D. (2015). Mutations in cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Brain, 138(9), 2493–2504. https://doi.org/10.1093/brain/awv185
Benatar, M., Boylan, K., Jeromin, A., Rutkove, S. B., Berry, J., Atassi, N., & Bruijn, L. (2016). ALS biomarkers for therapy development: State of the field and future directions. Muscle & Nerve, 53(2), 169–182. https://doi.org/10.1002/mus.24979
Berlowitz, D. J., Howard, M. E., Fiore, J. F., Vander Hoorn, S., O’Donoghue, F. J., Westlake, J., Smith, A., Beer, F., Mathers, S., & Talman, P. (2016). Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. Journal of Neurology, Neurosurgery & Psychiatry, 87(3), 280–286. https://doi.org/10.1136/jnnp-2014-310055
Birnkrant, D. J., Bushby, K., Bann, C. M., Alman, B. A., Apkon, S. D., Blackwell, A., Case, L. E., Cripe, L., Hadjiyannakis, S., Olson, A. K., Sheehan, D. W., Bolen, J., Weber, D. R., & Ward, L. M. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology, 17(4), 347–361. https://doi.org/10.1016/S1474-4422(18)30025-5
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., Street, N., Tomezsko, J., Wagner, K. R., Ward, L. M., & Weber, D. R. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology, 17(3), 251–267. https://doi.org/10.1016/S1474-4422(18)30024-3
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Colvin, M. K., Cripe, L., Herron, A. R., Kennedy, A., Kinnett, K., Naprawa, J., Noritz, G., Poysky, J., Street, N., Trout, C. J., Weber, D. R., & Ward, L. M. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. The Lancet Neurology, 17(5), 445–455. https://doi.org/10.1016/S1474-4422(18)30026-7
Bonanomi, D., & Pfaff, S. L. (2010). Motor Axon Pathfinding. Cold Spring Harbor Perspectives in Biology, 2(3), a001735–a001735. https://doi.org/10.1101/cshperspect.a001735
Brownstone, R. M., & Bui, T. V. (2010). Spinal interneurons providing input to the final common path during locomotion. In Breathe, Walk and Chew: The Neural Challenge: Part I (Vol. 187, pp. 81–95). Elsevier. https://doi.org/10.1016/B978-0-444-53613-6.00006-X
Carrì, M. T., D’Ambrosi, N., & Cozzolino, M. (2017). Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochemical and Biophysical Research Communications, 483(4), 1187–1193. https://doi.org/10.1016/j.bbrc.2016.07.055
Cortes, C. J., Ling, S.-C., Guo, L. T., Hung, G., Tsunemi, T., Ly, L., Tokunaga, S., Lopez, E., Sopher, B. L., Bennett, C. F., Shelton, G. D., Cleveland, D. W., & La Spada, A. R. (2014). Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy. Neuron, 82(2), 295–307. https://doi.org/10.1016/j.neuron.2014.03.001
Couratier, P., Corcia, P., Lautrette, G., Nicol, M., Preux, P.-M., & Marin, B. (2016). Epidemiology of amyotrophic lateral sclerosis: A review of literature. Revue Neurologique, 172(1), 37–45. https://doi.org/10.1016/j.neurol.2015.11.002
Crisp, S. J., Kullmann, D. M., & Vincent, A. (2016a). Autoimmune synaptopathies. Nature Reviews Neuroscience, 17(2), 103–117. https://doi.org/10.1038/nrn.2015.27
Crisp, S. J., Kullmann, D. M., & Vincent, A. (2016b). Autoimmune synaptopathies. Nature Reviews Neuroscience, 17(2), 103–117. https://doi.org/10.1038/nrn.2015.27
Cruz, P. M. R., Palace, J., & Beeson, D. (2014). Congenital myasthenic syndromes and the neuromuscular junction. Current Opinion in Neurology, 27(5), 566–575. https://doi.org/10.1097/WCO.0000000000000134
Darabid, H., Perez-Gonzalez, A. P., & Robitaille, R. (2014). Neuromuscular synaptogenesis: coordinating partners with multiple functions. Nature Reviews Neuroscience, 15(11), 703–718. https://doi.org/10.1038/nrn3821
Dasen, J. S., & Jessell, T. M. (2009). Chapter Six Hox Networks and the Origins of Motor Neuron Diversity. In Hox Genes (Vol. 88, pp. 169–200). Elsevier. https://doi.org/10.1016/S0070-2153(09)88006-X
Drory, V. E., Goltsman, E., Goldman Reznik, J., Mosek, A., & Korczyn, A. D. (2001). The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191(1–2), 133–137. https://doi.org/10.1016/S0022-510X(01)00610-4
Engel, A. G., Shen, X.-M., Selcen, D., & Sine, S. M. (2015). Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. The Lancet Neurology, 14(4), 420–434. https://doi.org/10.1016/S1474-4422(14)70201-7
Finkel, R. S., Mercuri, E., Meyer, O. H., Simonds, A. K., Schroth, M. K., Graham, R. J., Kirschner, J., Iannaccone, S. T., Crawford, T. O., Woods, S., Muntoni, F., Wirth, B., Montes, J., Main, M., Mazzone, E. S., Vitale, M., Snyder, B., Quijano-Roy, S., Bertini, E., … Sejersen, T. (2018). Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscular Disorders, 28(3), 197–207. https://doi.org/10.1016/j.nmd.2017.11.004
Fratta, P., Nirmalananthan, N., Masset, L., Skorupinska, I., Collins, T., Cortese, A., Pemble, S., Malaspina, A., Fisher, E. M. C., Greensmith, L., & Hanna, M. G. (2014). Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology, 82(23), 2077–2084. https://doi.org/10.1212/WNL.0000000000000507
Fuller, G., & Manford, M. (2010). Neurology: an illustrated colour text (3rd ed). Churchill Livingstone Elsevier. http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3669595080004761&institutionId=4761&customerId=4760
Gendron, T. F., Chew, J., Stankowski, J. N., Hayes, L. R., Zhang, Y.-J., Prudencio, M., Carlomagno, Y., Daughrity, L. M., Jansen-West, K., Perkerson, E. A., O’Raw, A., Cook, C., Pregent, L., Belzil, V., van Blitterswijk, M., Tabassian, L. J., Lee, C. W., Yue, M., Tong, J., … Prelle, A. (2017). Poly(GP) proteins are a useful pharmacodynamic marker for -associated amyotrophic lateral sclerosis. Science Translational Medicine, 9(383). https://doi.org/10.1126/scitranslmed.aai7866
Gibson, S., & Haringer, V. (2015). Amyotrophic lateral sclerosis: clinical perspectives. Orphan Drugs: Research and Reviews. https://doi.org/10.2147/ODRR.S63585
Gilhus, N. E. (2016). Myasthenia Gravis. New England Journal of Medicine, 375(26), 2570–2581. https://doi.org/10.1056/NEJMra1602678
Gordon, E., Rohrer, J. D., & Fox, N. C. (2016). Advances in neuroimaging in frontotemporal dementia. Journal of Neurochemistry, 138, 193–210. https://doi.org/10.1111/jnc.13656
Harland, R. (2000). Neural induction. Current Opinion in Genetics & Development, 10(4), 357–362. https://doi.org/10.1016/S0959-437X(00)00096-4
Harwood, C. A., McDermott, C. J., & Shaw, P. J. (2012). Clinical aspects of motor neurone disease. Medicine, 40(10), 540–545. https://doi.org/10.1016/j.mpmed.2012.07.003
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011). Principles of early drug discovery. British Journal of Pharmacology, 162(6), 1239–1249. https://doi.org/10.1111/j.1476-5381.2010.01127.x
Jacobson, L., Polizzi, A., Morriss-Kay, G., & Vincent, A. (1999). Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. Journal of Clinical Investigation, 103(7), 1031–1038. https://doi.org/10.1172/JCI5943
Jessell, T. M. (2000). Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nature Reviews Genetics, 1(1), 20–29. https://doi.org/10.1038/35049541
Jones, R. A., Harrison, C., Eaton, S. L., Llavero Hurtado, M., Graham, L. C., Alkhammash, L., Oladiran, O. A., Gale, A., Lamont, D. J., Simpson, H., Simmen, M. W., Soeller, C., Wishart, T. M., & Gillingwater, T. H. (2017). Cellular and Molecular Anatomy of the Human Neuromuscular Junction. Cell Reports, 21(9), 2348–2356. https://doi.org/10.1016/j.celrep.2017.11.008
Kanning, K. C., Kaplan, A., & Henderson, C. E. (2010). Motor Neuron Diversity in Development and Disease. Annual Review of Neuroscience, 33(1), 409–440. https://doi.org/10.1146/annurev.neuro.051508.135722
Koneczny, I., Cossins, J., & Vincent, A. (2014). The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis. Journal of Anatomy, 224(1), 29–35. https://doi.org/10.1111/joa.12034
Koneczny, I., Cossins, J., Waters, P., Beeson, D., & Vincent, A. (2013). MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters. PLoS ONE, 8(11). https://doi.org/10.1371/journal.pone.0080695
Kusner, L. L., & Kaminski, H. J. (2015). Myasthenia Gravis. In Neurobiology of Brain Disorders (pp. 135–150). Elsevier. https://doi.org/10.1016/B978-0-12-398270-4.00010-0
Ladle, D. R., Pecho-Vrieseling, E., & Arber, S. (2007). Assembly of Motor Circuits in the Spinal Cord: Driven to Function by Genetic and Experience-Dependent Mechanisms. Neuron, 56(2), 270–283. https://doi.org/10.1016/j.neuron.2007.09.026
Laurá, M., Singh, D., Ramdharry, G., Morrow, J., Skorupinska, M., Pareyson, D., Burns, J., Lewis, R. A., Scherer, S. S., Herrmann, D. N., Cullen, N., Bradish, C., Gaiani, L., Martinelli, N., Gibbons, P., Pfeffer, G., Phisitkul, P., Wapner, K., Sanders, J., … Reilly, M. M. (2018). Prevalence and orthopedic management of foot and ankle deformities in Charcot-Marie-Tooth disease. Muscle & Nerve, 57(2), 255–259. https://doi.org/10.1002/mus.25724
Leung, D. G. (2017). Other Proven and Putative Autoimmune Disorders of the Peripheral Nervous System (Vol. 1). Oxford University Press. https://doi.org/10.1093/med/9780199937837.003.0098
Li, L., Xiong, W.-C., & Mei, L. (2018). Neuromuscular Junction Formation, Aging, and Disorders. Annual Review of Physiology, 80(1), 159–188. https://doi.org/10.1146/annurev-physiol-022516-034255
Lieberman, A. P., Yu, Z., Murray, S., Peralta, R., Low, A., Guo, S., Yu, X. X., Cortes, C. J., Bennett, C. F., Monia, B. P., La Spada, A. R., & Hung, G. (2014). Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy. Cell Reports, 7(3), 774–784. https://doi.org/10.1016/j.celrep.2014.02.008
Lin, G., Mao, D., & Bellen, H. J. (2017). Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload. In Fly Models of Human Diseases (Vol. 121, pp. 111–171). Elsevier. https://doi.org/10.1016/bs.ctdb.2016.07.004
Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., Orrell, R., Howard, R., Talbot, K., Greensmith, L., Kuhle, J., Turner, M. R., & Malaspina, A. (2015). Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology, 84(22), 2247–2257. https://doi.org/10.1212/WNL.0000000000001642
Malik, B., Nirmalananthan, N., Bilsland, L. G., La Spada, A. R., Hanna, M. G., Schiavo, G., Gallo, J.-M., & Greensmith, L. (2011). Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Human Molecular Genetics, 20(9), 1776–1786. https://doi.org/10.1093/hmg/ddr061
Malik, B., Nirmalananthan, N., Gray, A. L., La Spada, A. R., Hanna, M. G., & Greensmith, L. (2013). Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy. Brain, 136(3), 926–943. https://doi.org/10.1093/brain/aws343
Manzano, R., Sorarú, G., Grunseich, C., Fratta, P., Zuccaro, E., Pennuto, M., & Rinaldi, C. (2018). Beyond motor neurons: expanding the clinical spectrum in Kennedy’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 89(8), 808–812. https://doi.org/10.1136/jnnp-2017-316961
Maragakis, N. J. (2017). What can we learn from the edaravone development program for ALS? Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(sup1), 98–103. https://doi.org/10.1080/21678421.2017.1361446
Mazzone, E. S., Mayhew, A., Montes, J., Ramsey, D., Fanelli, L., Young, S. D., Salazar, R., De Sanctis, R., Pasternak, A., Glanzman, A., Coratti, G., Civitello, M., Forcina, N., Gee, R., Duong, T., Pane, M., Scoto, M., Pera, M. C., Messina, S., … Mercuri, E. (2017). Revised upper limb module for spinal muscular atrophy: Development of a new module. Muscle & Nerve, 55(6), 869–874. https://doi.org/10.1002/mus.25430
Mercuri, E., Finkel, R. S., Muntoni, F., Wirth, B., Montes, J., Main, M., Mazzone, E. S., Vitale, M., Snyder, B., Quijano-Roy, S., Bertini, E., Davis, R. H., Meyer, O. H., Simonds, A. K., Schroth, M. K., Graham, R. J., Kirschner, J., Iannaccone, S. T., Crawford, T. O., … Dubousset, J. (2018). Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscular Disorders, 28(2), 103–115. https://doi.org/10.1016/j.nmd.2017.11.005
Meriggioli, M. N., & Sanders, D. B. (2009). Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. The Lancet Neurology, 8(5), 475–490. https://doi.org/10.1016/S1474-4422(09)70063-8
Milioto, C., Malena, A., Maino, E., Polanco, M. J., Marchioretti, C., Borgia, D., Pereira, M. G., Blaauw, B., Lieberman, A. P., Venturini, R., Plebani, M., Sambataro, F., Vergani, L., Pegoraro, E., Sorarù, G., & Pennuto, M. (2017). Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Scientific Reports, 7(1). https://doi.org/10.1038/srep41046
Mitsumoto, H., Brooks, B. R., & Silani, V. (2014). Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? The Lancet Neurology, 13(11), 1127–1138. https://doi.org/10.1016/S1474-4422(14)70129-2
Monahan, Z., Shewmaker, F., & Pandey, U. B. (2016). Stress granules at the intersection of autophagy and ALS. Brain Research, 1649, 189–200. https://doi.org/10.1016/j.brainres.2016.05.022
Morgan, S., & Orrell, R. W. (2016). Pathogenesis of amyotrophic lateral sclerosis. British Medical Bulletin, 119(1), 87–98. https://doi.org/10.1093/bmb/ldw026
Morren, J. A., & Galvez-Jimenez, N. (2012). Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs, 21(3), 297–320. https://doi.org/10.1517/13543784.2012.657303
Motor neurone disease: assessment and management | Guidance and guidelines | NICE. (n.d.). https://www.nice.org.uk/guidance/ng42
Nishimune, H., Valdez, G., Jarad, G., Moulson, C. L., Müller, U., Miner, J. H., & Sanes, J. R. (2008). Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. The Journal of Cell Biology, 182(6), 1201–1215. https://doi.org/10.1083/jcb.200805095
O’Connor, E., Töpf, A., Zahedi, R. P., Spendiff, S., Cox, D., Roos, A., & Lochmüller, H. (2018). Clinical and research strategies for limb-girdle congenital myasthenic syndromes. Annals of the New York Academy of Sciences, 1412(1), 102–112. https://doi.org/10.1111/nyas.13520
Orrell, Richard WBarclay, Chris. (n.d.). Diagnosis and management of motor neurone disease. Practitioner, 260, 17–21. https://search.proquest.com/docview/1844334383/64C39DCAF3D346C0PQ/1?accountid=14511
Otto, M., Bowser, R., Turner, M., Berry, J., Brettschneider, J., Connor, J., Costa, J., Cudkowicz, M., Glass, J., Jahn, O., Lehnert, S., Malaspina, A., Parnetti, L., Petzold, A., Shaw, P., Sherman, A., Steinacker, P., Süßmuth, S., Teunissen, C., … Ludolph, A. (2012). Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotrophic Lateral Sclerosis, 13(1), 1–10. https://doi.org/10.3109/17482968.2011.627589
Peragallo, J. H. (2017). Pediatric Myasthenia Gravis. Seminars in Pediatric Neurology, 24(2), 116–121. https://doi.org/10.1016/j.spen.2017.04.003
Ramdharry, G. M., Pollard, A., Anderson, C., Laurá, M., Murphy, S. M., Dudziec, M., Dewar, E. L., Hutton, E., Grant, R., & Reilly, M. M. (2014). A pilot study of proximal strength training in Charcot-Marie-Tooth disease. Journal of the Peripheral Nervous System, 19(4), 328–332. https://doi.org/10.1111/jns.12100
Ramsey, D., Scoto, M., Mayhew, A., Main, M., Mazzone, E. S., Montes, J., de Sanctis, R., Dunaway Young, S., Salazar, R., Glanzman, A. M., Pasternak, A., Quigley, J., Mirek, E., Duong, T., Gee, R., Civitello, M., Tennekoon, G., Pane, M., Pera, M. C., … Muntoni, F. (2017). Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool. PLOS ONE, 12(2). https://doi.org/10.1371/journal.pone.0172346
Reilly, M. M., Pareyson, D., Burns, J., Laurá, M., Shy, M. E., Singh, D., Agren, P. H., Altmann, V., Baets, J., Briggs, P., Burns, J., Butcher, K., Gaiani, L., Genovese, F., Gibbons, P., Laurá, M., Louwerens, J. W., Manzur, A., Moroni, I., … Wenz, W. (2017). 221st ENMC International Workshop: Neuromuscular Disorders, 27(12), 1138–1142. https://doi.org/10.1016/j.nmd.2017.09.005
Renton, A. E., Chiò, A., & Traynor, B. J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nature Neuroscience, 17(1), 17–23. https://doi.org/10.1038/nn.3584
Rodríguez Cruz, P. M., Palace, J., & Beeson, D. (2014). Inherited disorders of the neuromuscular junction: an update. Journal of Neurology, 261(11), 2234–2243. https://doi.org/10.1007/s00415-014-7520-7
Rodríguez Cruz, P. M., Sewry, C., Beeson, D., Jayawant, S., Squier, W., McWilliam, R., & Palace, J. (2014). Congenital myopathies with secondary neuromuscular transmission defects; A case report and review of the literature. Neuromuscular Disorders, 24(12), 1103–1110. https://doi.org/10.1016/j.nmd.2014.07.005
Rudolf, R., Khan, M. M., Labeit, S., & Deschenes, M. R. (2014). Degeneration of Neuromuscular Junction in Age and Dystrophy. Frontiers in Aging Neuroscience, 6. https://doi.org/10.3389/fnagi.2014.00099
Ruegsegger, C., & Saxena, S. (2016). Proteostasis impairment in ALS. Brain Research, 1648, 571–579. https://doi.org/10.1016/j.brainres.2016.03.032
Scoto, M., Finkel, R. S., Mercuri, E., & Muntoni, F. (2017). Therapeutic approaches for spinal muscular atrophy (SMA). Gene Therapy, 24(9), 514–519. https://doi.org/10.1038/gt.2017.45
Singhal, N., & Martin, P. T. (2011). Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction. Developmental Neurobiology, 71(11), 982–1005. https://doi.org/10.1002/dneu.20953
Spillane, J., Beeson, D. J., & Kullmann, D. M. (2010). Myasthenia and related disorders of the neuromuscular junction. Journal of Neurology, Neurosurgery & Psychiatry, 81(8), 850–857. https://doi.org/10.1136/jnnp.2008.169367
Spillane, J., Ermolyuk, Y., Cano-Jaimez, M., Lang, B., Vincent, A., Volynski, K. E., & Kullmann, D. M. (2015). Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels. Neurology, 84(6), 575–579. https://doi.org/10.1212/WNL.0000000000001225
Viegas, S., Jacobson, L., Waters, P., Cossins, J., Jacob, S., Leite, M. I., Webster, R., & Vincent, A. (2012). Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects. Experimental Neurology, 234(2), 506–512. https://doi.org/10.1016/j.expneurol.2012.01.025
Vincent, A. (2002). Unravelling the pathogenesis of myasthenia gravis. Nature Reviews Immunology, 2(10), 797–804. https://doi.org/10.1038/nri916
Volume 58, Issue 3, March 2016. (n.d.). Volume 58, Issue 3, March 2016. https://link.springer.com/journal/12031/58/3
Westerberg, E., Molin, C. J., Spörndly Nees, S., Widenfalk, J., & Punga, A. R. (2018). The impact of physical exercise on neuromuscular function in Myasthenia gravis patients. Medicine, 97(31). https://doi.org/10.1097/MD.0000000000011510
Wolfe, G. I., Kaminski, H. J., Aban, I. B., Minisman, G., Kuo, H.-C., Marx, A., Ströbel, P., Mazia, C., Oger, J., Cea, J. G., Heckmann, J. M., Evoli, A., Nix, W., Ciafaloni, E., Antonini, G., Witoonpanich, R., King, J. O., Beydoun, S. R., Chalk, C. H., … Cutter, G. R. (2016). Randomized Trial of Thymectomy in Myasthenia Gravis. New England Journal of Medicine, 375(6), 511–522. https://doi.org/10.1056/NEJMoa1602489
Woollacott, I. O. C., & Rohrer, J. D. (2016). The clinical spectrum of sporadic and familial forms of frontotemporal dementia. Journal of Neurochemistry, 138, 6–31. https://doi.org/10.1111/jnc.13654
